Role of fructooligosaccharides in promoting beneficial gut bacteria: A Prebiotic perspective

被引:5
作者
Singh, Pallavi [1 ]
Gupta, Shyam Kumar [1 ]
Kundu, Aditi [1 ]
Grover, Minakshi [2 ]
Saha, Supradip [1 ]
机构
[1] ICAR Indian Agr Res Inst, Div Agr Chem, New Delhi 110012, India
[2] ICAR Indian Agr Res Inst, Div Microbiol, New Delhi 110012, India
关键词
Dietary fiber; Fructo-oligosaccharides; Non-digestible carbohydrates; Prebiotics; Short-chain fatty acids; Characterization; ANION-EXCHANGE CHROMATOGRAPHY; CHAIN FATTY-ACIDS; LIQUID-CHROMATOGRAPHY; DIETARY FIBER; MICROBIOTA; INULIN; OLIGOSACCHARIDES; METABOLISM; LEVANASE; HEALTH;
D O I
10.1016/j.fbio.2024.105726
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Prebiotics, including both natural and synthetic non-digestible carbohydrate substances, have gained significant attention for their ability to support the proliferation of beneficial gut microbes. Among these, fructooligosaccharides (FOS) play a crucial role as substrates within the digestive system, aiding in producing of shortchain fatty acids by beneficial microorganisms, thus promoting their growth. The benefits of prebiotics in modulating gut microbiota, enhancing mineral absorption, and managing conditions such as diabetes, allergies, and metabolic disorders have led to increased interest in their applications in the pharmaceutical and food industries, with some products already available as supplements. Biosynthesis of FOS not only takes place in plant systems but enzymes responsible for the synthesis of these oligosaccharides are present in fungi and bacterial cells. Characterization of FOS mainly molecular weight and structural identification can be done with spectroscopic and chromatographic techniques. Modulation of the gut microbiome through prebiotic interventions is also reported. This comprehensive review focuses on fructooligosaccharides, highlighting their evolving roles in dietary interventions and potential future research directions. By addressing key challenges and exploring possible advancements, this review seeks to contribute to the ongoing efforts to understand and harness the therapeutic potential of prebiotics for human health.
引用
收藏
页数:13
相关论文
共 154 条
[81]   Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review [J].
Mirmiran, Parvin ;
Bahadoran, Zahra ;
Azizi, Fereidoun .
WORLD JOURNAL OF DIABETES, 2014, 5 (03) :267-281
[82]   Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii [J].
Moens, Frederic ;
Weckx, Stefan ;
De Vuyst, Luc .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2016, 231 :76-85
[83]   The role of the microbiome for human health: from basic science to clinical applications [J].
Mohajeri, M. Hasan ;
Brummer, Robert J. M. ;
Rastall, Robert A. ;
Weersma, Rinse K. ;
Harmsen, Hermie J. M. ;
Faas, Marijke ;
Eggersdorfer, Manfred .
EUROPEAN JOURNAL OF NUTRITION, 2018, 57 :S1-S14
[84]   Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus [J].
Moreno-Indias, Isabel ;
Cardona, Fernando ;
Tinahones, Francisco J. ;
Isabel Queipo-Ortuno, Maria .
FRONTIERS IN MICROBIOLOGY, 2014, 5
[85]   Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism [J].
Morrison, Douglas J. ;
Preston, Tom .
GUT MICROBES, 2016, 7 (03) :189-200
[86]   Modification of citrus and apple pectin by power ultrasound: Effects of acid and enzymatic treatment [J].
Munoz-Almagro, Nerea ;
Montilla, Antonia ;
Javier Moreno, F. ;
Villamiel, Mar .
ULTRASONICS SONOCHEMISTRY, 2017, 38 :807-819
[87]   Microbial enzymatic production and applications of short-chain fructooligosaccharides and inulooligosaccharides: recent advances and current perspectives [J].
Mutanda, T. ;
Mokoena, M. P. ;
Olaniran, A. O. ;
Wilhelmi, B. S. ;
Whiteley, C. G. .
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2014, 41 (06) :893-906
[88]  
Nabarlatz D. A., 2007, By-products for the production of xylo-oligosaccharides
[89]  
Nobre C., 2022, Current developments in Biotechnology and Bioengineering, P109, DOI [DOI 10.1016/B978-0-12-823506-5.00002-3, 10.1016/B978-0-12-823506-5.00002-3, DOI 10.1016/B978-0-12-823506-5]
[90]  
Nwafor I. C., 2017, SCI WORLD J, V2017, DOI 10.1155/2017/7343928